PIE - Posterior Segment • Innovation • Enlightenment

November 29, 2024

Can this Novel mRNA Therapy for PVR from Mass Eye and Ear Prevent Blindness?

The therapy, dubbed RUNX1-Trap, reduced excess scar tissue and the formation of new scar tissue in cultured cells and animal…

All previous issues

September 16, 2024

PIE Issue 31: The EURETINA 2024 Issue

explore ebooks

Videos

November 19, 2024

Roche x APVRS 2024: When Game Shows Meets Ocular Science

Espansione Thumbnail ESCRS Booth talk #1

October 17, 2024

me-check® pro: Data and Firsthand Experiences With a Novel AI-Powered Screening Solution for MGD

Thumbnail LKC Rapid Video at EURETINA 2024

September 20, 2024

Modern ERG Demystified: Beginner and Advanced Courses at EURETINA 2024

Posterior Segment

November 29, 2024

Can this Novel mRNA Therapy for PVR from Mass Eye and Ear Prevent Blindness?

WhatsApp Image 2024 11 25 at 10.06.27 am

December 2, 2024

SUBTHRESHOLD LASER TREATMENT—To Titrate or Not to Titrate?

November 30, 2024

Unpacking a Macular Mystery

Innovation

September 27, 2024

Neuralink’s Blindsight Implant Receives FDA Breakthrough Device Designation

March 29, 2024

Pioneering Robotic Retinal Surgery Ushers in New Era of Ophthalmic Automation

March 4, 2024

Ocular Imaging: Discovering Groundbreaking Studies that Stole the Spotlight at APVRS 2023

Enlightenment

October 29, 2024

Seeing Beyond the Horizon: How Research Collaborations are Advancing Eye Care in Asia-Pacific

October 22, 2024

Ocular Oncology for General Ophthalmologists: Top Tips from AAO 2024

July 23, 2024

Dr. Tara George, Eyeconic Woman

Conference Highlights

November 30, 2024

Unpacking a Macular Mystery

November 24, 2024

APVRS 2024 Day 3: End of the Line and a Stranger in a (Sort of) Strange Land

November 24, 2024

GA Management: A Tale of Innovation and Caution at APVRS 2024

Cover Story

November 24, 2024

APVRS 2024 Day 3: End of the Line and a Stranger in a (Sort of) Strange Land

November 23, 2024

APVRS 2024 Day 2: A Blast From the Past Into the Future

October 2, 2024

Can this Novel mRNA Therapy for PVR from Mass Eye and Ear Prevent Blindness?

PIE Issue 31: The EURETINA 2024 Issue

Roche x APVRS 2024: When Game Shows Meets Ocular Science

me-check® pro: Data and Firsthand Experiences With a Novel AI-Powered Screening Solution for MGD

Modern ERG Demystified: Beginner and Advanced Courses at EURETINA 2024

Can this Novel mRNA Therapy for PVR from Mass Eye and Ear Prevent Blindness?

SUBTHRESHOLD LASER TREATMENT—To Titrate or Not to Titrate?

Unpacking a Macular Mystery

Neuralink’s Blindsight Implant Receives FDA Breakthrough Device Designation

Pioneering Robotic Retinal Surgery Ushers in New Era of Ophthalmic Automation

Ocular Imaging: Discovering Groundbreaking Studies that Stole the Spotlight at APVRS 2023

Seeing Beyond the Horizon: How Research Collaborations are Advancing Eye Care in Asia-Pacific

Ocular Oncology for General Ophthalmologists: Top Tips from AAO 2024

Dr. Tara George, Eyeconic Woman

Unpacking a Macular Mystery

APVRS 2024 Day 3: End of the Line and a Stranger in a (Sort of) Strange Land

GA Management: A Tale of Innovation and Caution at APVRS 2024

APVRS 2024 Day 3: End of the Line and a Stranger in a (Sort of) Strange Land

APVRS 2024 Day 2: A Blast From the Past Into the Future

The Promise of Gene Therapy in Retinal Disorders

Read The Latest Ebook

meet the editorial team

Read The Latest Ebook

meet the editorial team

subscribe to receive our latest publications

PIE Magazine